Skip to content

Chlorhexidine & Pneumonia in Nursing Home Residents

Effect of Topical Oral Chlorhexidine in Reducing Pneumonia in Nursing Home Residents

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00841074
Enrollment
75
Registered
2009-02-11
Start date
2006-01-31
Completion date
2011-07-31
Last updated
2017-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pneumonia, Respiratory Infection

Keywords

Pneumonia, Elderly, Chlorhexidine, Respiratory pathogens

Brief summary

The purpose of this study is determine if topical oral application of a chlorhexidine antimicrobial spray will significantly reduce pneumonia and respiratory infections, and improve oral health compared to a placebo solution in nursing home residents.

Interventions

DRUGchlorhexidine

0.12% chlorhexidine mouthwash spray, \ 1.3 ml, twice a day.

DRUGPlacebo mouthwash

Placebo mouthwash spray application of \ 1.3 ml twice a day.

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR)
CollaboratorNIH
University of Louisville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Participants must be at least 65 years old. 2. Be dependent in 2 or more Activities of Daily Living as noted on the nursing home resident's Minimum Data Set - One must be ADL J- Personal Hygiene. 3. Have natural teeth and/or wear complete or partial dentures. 4. Expected to be a resident in a nursing home for two years.

Exclusion criteria

1. Existing pneumonia. 2. History of chlorhexidine reaction or allergy and/or multiple medication or substance allergies. 3. Receiving chlorhexidine oral application at enrollment as prescribed by physician or dentist.

Design outcomes

Primary

MeasureTime frame
Pneumonia12 months

Secondary

MeasureTime frame
Respiratory pathogens12 months
Plaque and Gingival Indices12 months

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026